- Differentiation of human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) into cardiovascular cells, including cardiomyocytes (CMs) and endothelial cells (ECs)
- Development of hiPSC-based cardiovascular disease models
- Molecular mechanisms of cardiovascular diseases using hiPSC-CMs and hiPSC-ECs
- Drug developmentand screening using patient-specific hiPSC-CMs and hiPSC-ECs
- Cardiac electrophysiology and pharmacology using hESC- and hiPSC-CMs
Last Modified: Page Views: 1208
中文